http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CS-260806-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7504ead7bc769ec70ee2ec9b1de2c482 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da438573526727fe196252b3465a5043 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate | 1986-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_945ed47c5b8b2354a99ea2e0adb954da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4da4051c8efdfb856eedbae13f9d4b0 |
| publicationDate | 1989-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CS-260806-B1 |
| titleOfInvention | Supplement of hybridoma and myeloma cell culture media |
| abstract | Supplement of hybridoma culture medianand myeloma cells are formed at leastnone water-soluble iron compound.nThe supplement may further containn2 χ 102 mg of biogenic trace compoundsn1 x 10 ”1 to 5 χ 103 mg of acidnascorbic, 1 x 10-5 to 5 "x 10" * mg steroidn2 to 7.5 x 102 mgnamines per mmol of water-soluble compoundsnirons. This supplement is a good substitutenprotein supplements such asnblood serum or pure protein |
| priorityDate | 1986-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.